| |
siRNA Id: | aspsirna0825
|
siRNA Name: | P2+P16_rs362307
|
Gene: | Hungtintin (HTT) |
Disease: | Huntington disease (HD) |
Wild allele/target (5'->3'): | GUCUGCGCCCUUGUGCCCUGC
|
Mutant allele/target (5'->3'): | GUCUGUGCCCUUGUGCCCUAC
|
Target Mutation: | c.52CAG(36_39)
|
Wild siRNA (As strand): | CAGACGCGGGAACACGGGACG
|
ASP-siRNA (As strand): | CAGACACGGGAACACGGGAUG
|
Mismatch position in siRNA: | U2C,A16G |
Mutant allele (5'->3'): | GUCUGUGCCCUUGUGCCCUAC
|
ASP-siRNA (As strand): | CAGACACGGGAACACGGGAUG
|
ASP-siRNA efficacy for mutant allele: | 58
|
Wild allele (5'->3'): | GUCUGCGCCCUUGUGCCCUGC
|
ASP-siRNA (As strand): | CAGACACGGGAACACGGGAUG
|
ASP-siRNA efficacy for wild allele: | 37
|
Percentage discrimination for ASP-siRNA: | 21
|
Wild allele (5'->3'): | GUCUGCGCCCUUGUGCCCUGC
|
Wild siRNA (As strand): | CAGACGCGGGAACACGGGACG
|
Wild sirna efficacy for wild allele: | 40
|
Wild allele (5'->3'): | GUCUGCGCCCUUGUGCCCUGC
|
ASP-siRNA (As strand): | CAGACACGGGAACACGGGAUG
|
Wild sirna efficacy for mutant allele: | 12
|
Percentage discrimination for wild siRNA: | 28
|
Concentration: | 20nM |
Orientation: | Sense |
Mismatch in: | siRNA |
UniProt ID: | Q96CV9 |
Target sequence: | GTCTGCGCCCTTGTGCCCTGCCTCCA |
Genbank Accesion: | NM_002111.7 |
Cell-line: | HeLa |
Experimental technique used: | Dual luciferase reporter assay |
Transfection method: | Lipofectamine 2000 |
siRNA expression method: | Invitrogen |
Post-transfection duration: | 48 hours |
OMID ID: | 143100 |
KEGG disease ID: | H00059 |
Reference: | 19361997 |